Supplementary Tables1 from Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer

Ritu Chaudhary; Graydon Moorhead; Robin Park; Jiannong Li; Michael J. Schell; Xiaofei Song; AikChoon Tan; Robbert J.C. Slebos; Maria I. Poole; Samuel S. Freeman; Sowjanya Thatikonda; Yeva Meshkovska; Juan Hernandez-Prera; Kedar Kirtane; Jose Alejandro Guevara-Patino; Antonio L. Amelio; James William Rocco; Brian P. Danysh; Marcelo Raul Bonomi; Nabil F. Saba; Nicholas J. Haradhvala; Gad A. Getz; Christine H. Chung

doi:10.1158/1078-0432.31248670

Supplementary Tables1 from Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer

2026 Open access

Read full text

Authors: Ritu Chaudhary, Graydon Moorhead, Robin Park, Jiannong Li, Michael J. Schell, Xiaofei Song, AikChoon Tan, Robbert J.C. Slebos, Maria I. Poole, Samuel S. Freeman, Sowjanya Thatikonda, Yeva Meshkovska

+11 more

Juan Hernandez-Prera, Kedar Kirtane, Jose Alejandro Guevara-Patino, Antonio L. Amelio, James William Rocco, Brian P. Danysh, Marcelo Raul Bonomi, Nabil F. Saba, Nicholas J. Haradhvala, Gad A. Getz, Christine H. Chung

DOI: 10.1158/1078-0432.31248670

Cited by: 0

Fields of Study & Subjects

Head and Neck Cancer Studies Cancer Immunotherapy and Biomarkers Colorectal Cancer Treatments and Studies

Publication details

Publication date: 4 February 2026